Reply to “EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma”

Annals of Surgical Oncology - United States
doi 10.1245/s10434-017-6181-z
Full Text
Abstract

Available in full text

Categories
OncologySurgery
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma

Annals of Surgical Oncology
OncologySurgery
2017English

PUB047 Efficacy of EGFR-TKI for Lung Adenosquamous Cell Carcinoma Harboring EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Survival Analysis for Lung Adenosquamous Carcinoma Patients With Brain Metastasis

Journal of Cancer
Oncology
2018English

Activation of the BMP-BMPR Pathway Conferred Resistance to EGFR-TKIs in Lung Squamous Cell Carcinoma Patients With EGFR Mutations

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

Oncology Letters
Cancer ResearchOncology
2014English

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal
2020English

EGFR Mutation Status in Tunisian Non-Small-Cell Lung Cancer Patients Evaluated by Mutation-Specific Immunohistochemistry

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

P2.09-12 EGFR Mutation Status in Squamous Cell Carcinoma or Non-Small Cell Carcinoma Favor Squamous Cell Carcinoma Diagnosed From Small Lung Biopsies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Severe Hepatotoxicity Due to Osimertinib After Nivolumab Therapy in Patients With Non‐small Cell Lung Cancer Harboring EGFR Mutation

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy